Search - tctmd.com

Displaying 561 - 580 of 698

Sort: Relevancy | Date

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Daily News

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Caitlin E. Cox

March 20, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

Presentation

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

Presenter: H. Shiomi

March 19, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation

Four-Year Clinical Outcomes and Predictors of Repeat Revascularization with New-Generation DES

Presenter: M. Taniwaki

February 18, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

Presentation TCT 2013

Importance of Incomplete Revascularization after PCI: Anticipating RIVER-PCI

Presenter: Giora Weisz

October 28, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

Advertisement

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Four-Year Clinical Outcomes and Predictors of Repeat Revascularization with New-Generation DES

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

Importance of Incomplete Revascularization after PCI: Anticipating RIVER-PCI

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content